12th International Symposium on Bordetella
第12届博德特氏菌国际研讨会
基本信息
- 批准号:9761709
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-05 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAdvertisingAnimal Disease ModelsAnimalsAwardBelgiumBiologyBordetellaBordetella pertussisClinicalCollaborationsCommunitiesCommunity NetworksCountryDeveloping CountriesDevelopmentDiseaseDomestic AnimalsEpidemiologistEpidemiologyEvolutionFosteringFundingFunding OpportunitiesFutureGenomicsHumanImmune responseImmunizationIndividualIndustryInfectionInternationalManufacturer NameMedicineMicrobiologyNotificationOralParticipantPathogenesisPertussisPertussis VaccinePhysiciansPostdoctoral FellowPreventionPrevention strategyProcessPublic HealthRecording of previous eventsResearchResearch PersonnelScientistStudentsTherapeuticTimeTravelUnderrepresented MinorityUniversitiesVaccine DesignVaccinesVirulence Factorsdata exchangedisease transmissiongraduate studentinnovationmeetingsnext generationnovelnovel vaccinespathogenpathogenic bacteriaposterspre-doctoralsymposiumtraining opportunitytranslational scientistvaccine developmentweb site
项目摘要
Project Summary/Abstract: Pertussis or whooping cough was once considered a disease of
the past but it is now one of the least controlled vaccine preventable diseases. Pertussis is
primarily caused by the Gram negative pathogen, Bordetella pertussis, but several other
Bordetellae cause similar diseases in humans as well as animals. The reemergence of
pertussis correlates with the transition to the acellular pertussis vaccines (DTaP and Tdap) in
the early 1990s. Since the 1960's the Bordetella research community has organized
international meetings which provide an opportunity for trainees, physicians, scientists,
epidemiologists, public health officials, and vaccine manufacturers to assemble and focus on
the problems together to move forward. The International Symposium occurs on a three-four
year cycle. The International Bordetella Symposium has served to build collaborations,
exchange ideas, establish priorities, and facilitate training opportunities for the next generation
of scientists. At the 11th symposium there were 50 oral presentations and 110 posters
presented by 196 attendees from 20 total countries. The 12th Symposium will be held at
Brussels University and will be hosted by Prof. Françoise Mascart and Dr. Camille Locht. The
organizing committee made up of 11 internationally known scientists who will directly participate
in the planning and administration of meeting. It is expected the 12th symposium will host 300
participants. The meeting agenda includes: Bordetella biology, genomics, evolution,
epidemiology, pathogenesis and virulence factors, animal models of disease and transmission,
immune responses to infection and immunization, vaccine design, as well as other important
topics. While there are numerous meetings that discuss bacterial pathogens, this is the only
symposium that exclusively focuses on Bordetella. In order to support development of the next
generation of scientists, this R13 application is requesting funds to support travel awards for
junior scientists (pre- and post-doctoral) to attend and present innovative research at the
12th International Bordetella Symposium in April 2019.
项目摘要/摘要:百日咳或百日咳曾经被认为是一种疾病,
过去,它是最不受控制的疫苗可预防疾病之一。百日咳是
主要由革兰氏阴性病原体百日咳博德特氏菌引起,但其他几种
博德特氏菌在人类和动物中引起类似的疾病。重新出现
百日咳与无细胞百日咳疫苗(DTaP和Tdap)的过渡有关,
90年代初。自20世纪60年代以来,博德特氏菌研究团体组织了
国际会议为受训人员、医生、科学家
流行病学家、公共卫生官员和疫苗制造商聚集在一起,
一起解决问题,共同前进。国际研讨会将于3月4日举行。
年周期。国际博德特氏菌研讨会有助于建立合作,
交流思想,确定优先事项,为下一代提供培训机会
科学家们。在第11届研讨会上,有50个口头报告和110张海报
共有来自20个国家的196名与会者出席。第十二届研讨会将于
会议将在布鲁塞尔大学举行,由Françoise Mascart教授和Camille Locht博士主持。的
组委会由11位国际知名科学家组成,他们将直接参与
会议的规划和管理。预计第12届研讨会将举办300场
参与者会议议程包括:博德特氏菌生物学,基因组学,进化,
流行病学、发病机理和毒力因子、疾病和传播的动物模型,
对感染和免疫的免疫反应、疫苗设计以及其他重要的
话题虽然有许多会议讨论细菌病原体,但这是唯一的
专门讨论博德特氏菌的研讨会。为了支持未来的发展,
这一代科学家,这个R13申请是要求资金,以支持旅行奖,
初级科学家(前和博士后)参加并提出创新研究,在
2019年4月第12届国际博德特氏菌研讨会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric T Harvill其他文献
Eric T Harvill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric T Harvill', 18)}}的其他基金
An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia
研究百日咳博德特氏菌与呼吸道上皮细胞相互作用的气液界面系统
- 批准号:
10665943 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10375566 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
- 批准号:
10364771 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10194677 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
In vivo vaccine-driven evolution in Bordetella pertussis
百日咳博德特氏菌体内疫苗驱动的进化
- 批准号:
8986495 - 财政年份:2015
- 资助金额:
$ 0.5万 - 项目类别:
Systematic evaluation of B. pertussis ACT’s role as a protective antigen
百日咳博德特氏菌 ACT 作为保护性抗原的作用的系统评估
- 批准号:
9056231 - 财政年份:2015
- 资助金额:
$ 0.5万 - 项目类别:
Evolution of the Bordetellae from Commensals to Pathogens
博德特氏菌从共生菌到病原体的进化
- 批准号:
7886472 - 财政年份:2009
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant